missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human TLR3 Synthetic Peptide

Catalog No. PEP0314
Change view
Click to view available options
Quantité:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantité
PEP0314 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PEP0314 Supplier Invitrogen™ Supplier No. PEP0314
Saison des économies
View all promotions

missing translation for 'validMainframeMsg'

Synthetic Peptide

This peptide corresponds to 15 amino acids near the amino terminus of human TLR3. PEP-0314 can be used as a blocking peptide with polyclonal antibody PA5-20184.

TLR3 (Toll-like receptor 3, CD283) is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from drosophila to humans and share structural and functional similarities. TLRs recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. TLR3 is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. TLR3 recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. Further, TLR3 may play a role in host defense against viruses, and the use of alternative polyadenylation sites to generate different length transcripts has been noted for the TLR3 gene. Like its counterparts in Drosophila, TLRs signal through adaptor molecules and could constitute an important and unrecognized component of innate immunity in humans. The TLR family is a phylogenetically conserved mediator of innate immunity that is essential for microbial recognition. TLRs characterized so far activate the MyD88/interleukin-1 receptor-associated kinase (IRAK) signaling pathway. TLR3 is the only human TLR which does not utilize MyD88 as an adaptor molecule instead utilizing TRIF in a signaling path which results in downstream activation of IRF-3 and NF-kB. TLR3 activation leads not only to Type I interferon induction but also to other inflammatory cytokines which result in DC maturation. TLR3 is known to recognize viral double-stranded (ds) RNA, a molecular pattern associated with viral infection. Recently it has been shown to recognize viruses such as Influenza A and West Nile Virus and can mediate entry of at least West Nile Virus.

Specifications

Espèces Human
Méthode de purification purified
Numéro d'enregistrement O15455
Nom usuel TLR3 (CD283)
Concentration 200 μg/mL
Format Liquid
Formule PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Alias du gène AI957183; CD283; IIAE2; TLR 3; TLR3; TLR-3; toll like receptor 3; toll-like receptor 3; toll-like receptor 3 variant 1
Symbole de gène TLR3
Lyophilisé No
Conservateur Sodium azide
Type de produit Peptide
Quantité 50 μg
Statut réglementaire RUO
Show More Show Less